Head-to-head · WeighScore
Evernow vs Fierce Health
The verdict
Evernow takes it — 58.8/100 to 56.6/100.
Evernow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Evernow is a women's-focused, menopause-centered telehealth platform that prescribes branded GLP-1 weight loss medications including Ozempic, Wegovy, Zepbound, and Mounjaro via US-licensed clinicians.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Evernow | Fierce Health |
|---|---|---|
| WeighScore | 58.8/100 | 56.6/100 |
| Grade | C | C |
| Scorecard rank | #356 | #411 |
| Semaglutide | Not disclosed | $297/mo (3-month plan, compounded) |
| Tirzepatide | Not disclosed | $497/mo (3-month plan, compounded) |
| Coverage | Coverage not published | 30 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #356 · C
Strengths
- Prescribes FDA-approved branded GLP-1s, not compounded
- Accepts insurance for video visits (BCBS, Anthem, UnitedHealthcare, Aetna)
- Integrates GLP-1 weight loss with menopause and HRT care
- Flexible one-time visit or low-cost membership models
Where it loses points
- Weight loss is one vertical alongside menopause and HRT care
- GLP-1 medication cost depends on insurance and is not posted
- State availability not specified on the site
Graded #411 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.